Rare diseases
Investigational molecules
Locations
Back to Latvia17 clinical trials in Valmiera, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)LatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on atherosclerotic cardiovascular disease and stroke prevention, evaluating new therapeutic approaches for patients with various heart conditions.
Research includes evaluation of novel compounds like asundexian and inclisiran for reducing major cardiovascular events.
Comprehensive studies addressing various bacterial infections, with particular focus on complicated urinary tract infections and pneumonia treatments.
Trials investigating new antibiotic combinations and therapeutic approaches for resistant infections.
Advanced research in cancer treatment, particularly focusing on prostate cancer management and innovative hormone therapy approaches.
Evaluation of darolutamide in combination with other therapies for improved patient outcomes.
Specialized research investigating treatments for Immunoglobulin A Nephropathy, focusing on innovative approaches to kidney disease management.
Clinical evaluation of povetacicept for improving kidney function and reducing disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
